BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27846313)

  • 1. Clinical and Genetic Analysis of Multiple Endocrine Neoplasia Type 1-Related Primary Hyperparathyroidism in Chinese.
    Kong J; Wang O; Nie M; Shi J; Hu Y; Jiang Y; Li M; Xia W; Meng X; Xing X
    PLoS One; 2016; 11(11):e0166634. PubMed ID: 27846313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trabecular Bone Score as a More Sensitive Tool to Evaluate Bone Involvement in MEN1-related Primary Hyperparathyroidism.
    Song A; Chen R; Guan W; Yu W; Yang Y; Wang J; Nie M; Jiang Y; Li M; Xia W; Xing X; Wang O
    J Clin Endocrinol Metab; 2023 Dec; 109(1):135-142. PubMed ID: 37539859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired geometry, volumetric density, and microstructure of cortical and trabecular bone assessed by HR-pQCT in both sporadic and MEN1-related primary hyperparathyroidism.
    Wang W; Nie M; Jiang Y; Li M; Meng X; Xing X; Wang O; Xia W
    Osteoporos Int; 2020 Jan; 31(1):165-173. PubMed ID: 31642976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical profile and treatment outcomes among patients with sporadic and multiple endocrine neoplasia syndrome-related primary hyperparathyroidism.
    Mathew UE; Goyal A; Upadhyay AD; Kandasamy D; Agarwal S; Sharma CK; Sharma A; Bal C; Tandon N; Jyotsna VP
    Clin Endocrinol (Oxf); 2023 Nov; 99(5):449-458. PubMed ID: 37393194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.
    Alvelos MI; Vinagre J; Fonseca E; Barbosa E; Teixeira-Gomes J; Sobrinho-Simões M; Soares P
    Eur J Endocrinol; 2013 Feb; 168(2):119-28. PubMed ID: 23093699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome.
    Tonelli F; Giudici F; Giusti F; Marini F; Cianferotti L; Nesi G; Brandi ML
    Eur J Endocrinol; 2014 Aug; 171(2):K7-K17. PubMed ID: 24819502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early-onset, progressive, frequent, extensive, and severe bone mineral and renal complications in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism.
    Lourenço DM; Coutinho FL; Toledo RA; Montenegro FL; Correia-Deur JE; Toledo SP
    J Bone Miner Res; 2010 Nov; 25(11):2382-91. PubMed ID: 20499354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathogenesis of primary hyperparathyroidism.
    Cetani F; Pardi E; Borsari S; Marcocci C
    J Endocrinol Invest; 2011 Jul; 34(7 Suppl):35-9. PubMed ID: 21985978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity.
    Eller-Vainicher C; Chiodini I; Battista C; Viti R; Mascia ML; Massironi S; Peracchi M; D'Agruma L; Minisola S; Corbetta S; Cole DE; Spada A; Scillitani A
    J Bone Miner Res; 2009 Aug; 24(8):1404-10. PubMed ID: 19309299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas.
    Borsari S; Pardi E; Pellegata NS; Lee M; Saponaro F; Torregrossa L; Basolo F; Paltrinieri E; Zatelli MC; Materazzi G; Miccoli P; Marcocci C; Cetani F
    Endocrine; 2017 Feb; 55(2):386-397. PubMed ID: 27038812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition.
    Vierimaa O; Villablanca A; Alimov A; Georgitsi M; Raitila A; Vahteristo P; Larsson C; Ruokonen A; Eloranta E; Ebeling TM; Ignatius J; Aaltonen LA; Leisti J; Salmela PI
    J Endocrinol Invest; 2009 Jun; 32(6):512-8. PubMed ID: 19474519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic defects associated with familial and sporadic hyperparathyroidism.
    Hendy GN; Cole DE
    Front Horm Res; 2013; 41():149-65. PubMed ID: 23652676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEN1 mutations and potentially MEN1-targeting miRNAs are responsible for menin deficiency in sporadic and MEN1 syndrome-associated primary hyperparathyroidism.
    Grolmusz VK; Borka K; Kövesdi A; Németh K; Balogh K; Dékány C; Kiss A; Szentpéteri A; Sármán B; Somogyi A; Csajbók É; Valkusz Z; Tóth M; Igaz P; Rácz K; Patócs A
    Virchows Arch; 2017 Sep; 471(3):401-411. PubMed ID: 28597079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Severe bone complications of primary hyperparathyroidism in a young patient with the rare verified mutation of
    Eremkina AK; Sazonova DV; Bibik EE; Sheikhova AZ; Khairieva AV; Buklemishev YV; Mokrysheva NG
    Probl Endokrinol (Mosk); 2022 Feb; 68(1):81-93. PubMed ID: 35262299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Operative intervention for primary hyperparathyroidism offers greater bone recovery in patients with sporadic disease than in those with multiple endocrine neoplasia type 1-related hyperparathyroidism.
    Silva AM; Vodopivec D; Christakis I; Lyons G; Wei Q; Waguespack SG; Petak SM; Grubbs E; Lee JE; Perrier N
    Surgery; 2017 Jan; 161(1):107-115. PubMed ID: 27842919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations.
    Igreja S; Chahal HS; Akker SA; Gueorguiev M; Popovic V; Damjanovic S; Burman P; Wass JA; Quinton R; Grossman AB; Korbonits M
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):259-64. PubMed ID: 18710468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and clinical screening for hereditary primary hyperparathyroidism in a large Chinese cohort: a single-center study.
    Song A; Yang Y; Jiang Y; Nie M; Jiang Y; Li M; Xia W; Xing X; Wang O
    J Bone Miner Res; 2023 Sep; 38(9):1322-1333. PubMed ID: 37449924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary hyperparathyroidism in Chinese children and adolescents: A single-centre experience at Peking Union Medical College Hospital.
    Wang W; Kong J; Nie M; Jiang Y; Li M; Xia W; Meng X; Xing X; Wang O
    Clin Endocrinol (Oxf); 2017 Dec; 87(6):865-873. PubMed ID: 28833384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile.
    Lourenço DM; Toledo RA; Mackowiak II; Coutinho FL; Cavalcanti MG; Correia-Deur JE; Montenegro F; Siqueira SA; Margarido LC; Machado MC; Toledo SP
    Eur J Endocrinol; 2008 Sep; 159(3):259-74. PubMed ID: 18524795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mutations in MEN1, CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain.
    Belar O; De La Hoz C; Pérez-Nanclares G; Castaño L; Gaztambide S;
    Clin Endocrinol (Oxf); 2012 May; 76(5):719-24. PubMed ID: 22026581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.